CME Group Inc. Files 8-K Report

TL;DR

CME Group filed a routine 8-K. Nothing major to see here.

AI Summary

On April 14, 2025, CME Group Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specific financial transactions or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates routine corporate reporting by CME Group Inc. to the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing appears to be a standard, routine disclosure without any immediate negative or positive financial implications.

Key Players & Entities

• CME Group Inc. (company) — Registrant
• April 14, 2025 (date) — Date of earliest event reported
• 20 South Wacker Drive Chicago, Illinois 60606 (address) — Principal executive offices
• 36-4459170 (tax_id) — IRS Employer Identification No.
• 001-31553 (company_id) — Commission File Number

FAQ

From the Filing

0001193125-25-079725.txt : 20250414 0001193125-25-079725.hdr.sgml : 20250414 20250414083543 ACCESSION NUMBER: 0001193125-25-079725 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250414 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 09 Crypto Assets EIN: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 25834285 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d857621d8k.htm 8-K 8-K false 0001156375 0001156375 2025-04-14 2025-04-14     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     FORM  8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2025     CME GROUP INC. (Exact name of registrant as specified in its charter)       Delaware   001-31553   36-4459170 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   20 South Wacker Drive Chicago , Illinois   60606 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (312)   930-1000 N/A (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Class A Common Stock   CME   The Nasdaq Stock Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 7.01 Regulation FD Disclosure. On April 14, 2025, CME Group Inc. (“CME Group”) issued a press release providing details with regard to its agreement to sell Osttra Group Ltd., a Bermuda exempted company, CME Group’s joint venture with S&P Global Inc. A copy of the press release, which is attached to this current report on Form 8-K as Exhibit 99.1, is furnished with this report as Exhibit 99.1 and is incorporated by reference in this Item 7.01. The information furnished under Item 7.01 of